Patrik Schadzek

Mr. Patrik Schadzek

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NFNina Friese
Nina Friese
MGMattis Gierschner
Mattis Gierschner
PSPatrik Schadzek
Patrik Schadzek
YRYvonne Roger
Yvonne Roger
AHAndrea Hoffmann
Andrea Hoffmann
Musculoskeletal dysfunctions are highly prevalent due to increasing life expectancy. Consequently, novel solutions to optimize treatment of patients are required. The current major research focus is to develop innovative concepts for single tissues. However, interest is also emerging to generate applications for tissue transitions where highly divergent properties need to work together, as in bone-cartilage or bone-tendon transitions. Finding medical solutions for dysfunctions of such tissue transitions presents an added challenge, both in research and in clinics. This review aims to provide an overview of the anatomical structure of healthy adult entheses and their development during embryogenesis. Subsequently, important scientific progress in restoration of damaged entheses is presented. With respect to enthesis dysfunction, the review further focuses on inflammation. Although molecular, cellular and tissue mechanisms during inflammation are well understood, tissue regeneration in context of inflammation still presents an unmet clinical need and goes along with unresolved biological questions. Furthermore, this review gives particular attention to the potential role of a signaling mediator protein, transforming growth factor beta-activated kinase-1 (TAK1), which is at the node of regenerative and inflammatory signaling and is one example for a less regarded aspect and potential important link between tissue regeneration and inflammation.

1 January 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
PSPatrik Schadzek
Patrik Schadzek
BSBarbara Schlingmann
Barbara Schlingmann
FSFrank Schaarschmidt
Frank Schaarschmidt
JLJulia Lindner
Julia Lindner
Michael KovalMichael Koval
Michael Koval
Anaclet NgezahayoAnaclet Ngezahayo
Anaclet Ngezahayo

5 October 2016 in International Journal of Oncology
Verified
Journal Article
Closed access
THTatjana Harting
Tatjana Harting
MSMandy Stubbendorff
Mandy Stubbendorff
SWSaskia Willenbrock
Saskia Willenbrock
SWSiegfried Wagner
Siegfried Wagner
PSPatrik Schadzek
Patrik Schadzek
INIngo Nolte
Ingo Nolte
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

1 October 2016 in Chemosphere
Verified
Journal Article
Closed access
AKAnn-Kathrin Kniggendorf
Ann-Kathrin Kniggendorf
Regina NogueiraRegina Nogueira
Regina Nogueira
CKChristian Kelb
Christian Kelb
PSPatrik Schadzek
Patrik Schadzek
MWMerve Wollweber
Merve Wollweber
Bernhard RothBernhard Roth
Bernhard Roth

28 July 2012 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
BSBarbara Schlingmann
Barbara Schlingmann
PSPatrik Schadzek
Patrik Schadzek
SBStefan Busko
Stefan Busko
AHAlexander Heisterkamp
Alexander Heisterkamp
Anaclet NgezahayoAnaclet Ngezahayo
Anaclet Ngezahayo

7 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
THTatjana P Harting
Tatjana P Harting
MSMandy Stubbendorff
Mandy Stubbendorff
SHSusanne C Hammer
Susanne C Hammer
PSPatrik Schadzek
Patrik Schadzek
Anaclet NgezahayoAnaclet Ngezahayo
Anaclet Ngezahayo
INIngo Nolte
Ingo Nolte
Targeting mitochondrial energy metabolism is a novel approach in cancer research and can be traced back to the description of the Warburg effect. Dichloroacetate, a controversially discussed subject of many studies in cancer research, is a pyruvate dehydrogenase kinase inhibitor. Dichloroacetate causes metabolic changes in cancerous glycolysis towards oxidative phosphorylation via indirect activation of pyruvate dehydrogenase in mitochondria. Canine mammary cancer is frequently diagnosed but after therapy prognosis still remains poor. In this study, canine mammary carcinoma, adenoma and non-neoplastic mammary gland cell lines were treated using 10 mM Dichloroacetate. The effect on cell number, lactate release and PDH expression and cell respiration was investigated. Further, the effect on apoptosis and several apoptotic proteins, proliferation, and microRNA expression was evaluated. Dichloroacetate was found to reduce cell proliferation without inducing apoptosis in all examined cell lines.